Risk factors

Elicio Therapeutics (ELTX) risk factors

Item 1A of every Elicio Therapeutics, Inc. 10-K on file, and what changed from one year to the next.

Open ELTX in Gloomberb →
  • FY2025 10-K risk factors

    90 risks, 13 new, 9 dropped, 28 reworded since the prior year. Elicio Therapeutics faces new risks regarding trade tariffs, early-stage clinical execution, and patent exclusivity for ELI-002.

    Filed Mar 12, 2026
  • FY2024 10-K risk factors

    86 risks. The risk section is dominated by severe going concern warnings, heavy reliance on external capital, and lack of approved commercial products.

    Filed Mar 31, 2025